378 related articles for article (PubMed ID: 15454245)
1. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
[TBL] [Abstract][Full Text] [Related]
2. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
4. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
Henry DH
Drugs; 2007; 67(2):175-94. PubMed ID: 17284083
[TBL] [Abstract][Full Text] [Related]
5. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
Cheer SM; Wagstaff AJ
Drugs; 2004; 64(3):323-46. PubMed ID: 14871172
[TBL] [Abstract][Full Text] [Related]
6. Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.
Oberhoff C
Support Care Cancer; 2007 Jun; 15(6):603-611. PubMed ID: 17277926
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).
Verbeke N; Beguin Y; Wildiers H; Canon JL; Bries G; Bosly A; Van Belle S
Support Care Cancer; 2012 Jan; 20(1):23-8. PubMed ID: 21107613
[TBL] [Abstract][Full Text] [Related]
8. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
9. [Use of erythropoietin in oncology].
Rosso R; Del Mastro L; Venturini M; Bergaglio M; Pasquetti W; Garrone O
Tumori; 1997; 83(4 Suppl 2):S26-30. PubMed ID: 9487381
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
11. Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events.
Aapro M; Osterwalder B; Scherhag A; Burger HU
Br J Cancer; 2009 Dec; 101(12):1961-71. PubMed ID: 19997109
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice.
Pujade-Lauraine E; Richard AJ; Sapède C; Hayward C
Oncol Rep; 2005 Oct; 14(4):1037-44. PubMed ID: 16142369
[TBL] [Abstract][Full Text] [Related]
13. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
14. [Guidelines for the treatment of anemia in chronic renal failure].
Triolo G;
G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
16. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
de Castro J; Belda-Iniesta C; Isla D; Dómine M; Sánchez A; Batiste E; Barón MG
Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
[TBL] [Abstract][Full Text] [Related]
17. Role of erythropoietin in cancer-related anaemia: a double-edged sword?
Guan X; Chen L
J Int Med Res; 2008; 36(1):1-8. PubMed ID: 18230261
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin or darbepoetin for patients with cancer.
Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
[TBL] [Abstract][Full Text] [Related]
19. A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia.
Ray-Coquard I; Laplaige P; Vey N; Asselain B; Urbieta M
Curr Med Res Opin; 2010 Nov; 26(11):2653-60. PubMed ID: 20932223
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]